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Diabetes affects approximately 1 million South Africans and 
contributes significantly to morbidity and mortality.1 In 2000, 
disability-adjusted life years for diabetes in South Africa 
(390/100 000) were comparable to US figures (421/100 000)2,3 
– 4 times higher than for the rest of Africa (113/100 000).3 
Diabetes expenditure per annum is not known in South Africa, 
but exceeds US$44 billion in the USA.4 Hospital admissions, the 
largest single item of diabetes expenditure in most countries, 
are related to ischaemic heart disease, cerebrovascular events, 
renal failure, foot pathology and hyperglycaemic emergencies.4 
Many admissions, especially hyperglycaemic emergencies, are 
potentially preventable with prompt diagnosis of diabetes, 
effective patient and health professional education, and 
comprehensive long-term care.4
G F Jooste Hospital (GFJH) is an urban 200-bed acute 
adult hospital, with 46 additional off-site district-level beds 
in Carnation ward (on the Lentegeur Hospital site, 10 km 
away). GFJH provides both district and regional-level services 
for an estimated 1.3 million people living in the Cape Town 
metropole; the communities served include Khayelitsha site 
B, Nyanga, Brown’s Farm, Crossroads, Gugulethu, Phillipi, 
Mitchell’s Plain, Heideveld and Strandfontein.5,6 GFJH’s 
admissions reflect South Africa’s quadruple burden of disease: 
HIV/AIDS, trauma, diseases of poverty (malnutrition and 
infectious diseases, e.g. tuberculosis), and diseases of lifestyle 
(e.g. hypertension and diabetes).7 A recent survey of medical 
admissions (N = 859) to the hospital’s 8-bed high-care unit 
(HCU) over a 12-month period indicated that 25.6% (N = 
220) were classified as hyperglycaemic emergencies.8 This 
prompted an evaluation of the reasons for, and financial costs 
of, hyperglycaemic admissions to GFJH. The purpose of the 
study was to gather data that would inform the development 
of appropriate primary- and secondary-level health care 
initiatives. This will allow re-allocation of finances from 
inpatient hyperglycaemic emergencies to the primary level 
prevention of diabetic complications. 
Methods
We conducted a prospective survey of all hyperglycaemic 
emergencies admitted to GFJH from 1 September to 31 October 
2005. A hyperglycaemic emergency was defined as any 
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Background and objectives. Diabetes affects approximately 
1 million South Africans. Hospital admissions, the largest 
single item of diabetes expenditure, are often precipitated 
by hyperglycaemic emergencies. A recent survey of a 200-
bed hospital, serving approximately 1.3 million Cape Town 
residents, showed that hyperglycaemic emergencies comprised 
25.6% of high-care unit admissions. A study was undertaken 
to determine the reasons for, and financial cost of, these 
admissions. 
Methods. All hyperglycaemic admissions during a 2-month 
period (1 September - 31 October 2005) were surveyed 
prospectively. Admissions were classified using the American 
Diabetes Association classification of hyperglycaemic 
emergencies. Demographic data, and the reason for, duration 
of and primary outcome of admission, were recorded. The 
following costs per admission were calculated using public-
sector pricing: (i) total costs; (ii) patient-specific costs; (iii) non-
patient-specific costs; and (iv) capital costs.  
Results. Sepsis (36%), non-compliance with therapy (32%) 
and a new diagnosis of diabetes (11%) were the predominant 
reasons for admission of 53 hyperglycaemic emergency cases. 
Mean duration of hospital stay was 4 days, with an in-hospital 
mortality of 7.5%. Mean cost per admission was R5 309. 
Clinical staff (25.8%), capital (25.6%) and overhead (34%) costs 
comprised 85.4% of expenditure. 
Discussion and recommendations. Hyperglycaemic admissions, 
costing more than R5 300 per patient, represent a health 
burden that has remained unchanged over the past 20 years. 
Urgently required primary care preventive strategies include 
early diagnosis of diabetes, timely identification and treatment 
of precipitating causes, specifically sepsis, and education to 
improve compliance. 
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patient with an elevated blood glucose concentration, and the 
perceived need by the admitting doctor to initiate intravenous 
insulin and fluid therapy.9,10 All hyperglycaemic emergencies 
were admitted to the HCU in order to ensure 2-hourly 
monitoring and supervision of intravenous insulin and fluid 
therapy; a lack of sufficient nursing staff in the general medical 
wards precludes such intensive monitoring. An intern was 
responsible for the daily management of these patients, while 
the medical registrar on call attended to problems after hours. 
Specialist physicians conducted daily HCU ward rounds. 
Because of limited nursing staff, minimal diabetic education 
was offered to hyperglycaemic patients admitted to GFJH.
Hyperglycaemic emergencies were classified according 
to the American Diabetes Association’s classification 
of hyperglycaemic emergencies.11 A further category, 
hyperosmolar diabetic ketoacidosis (HODKA), was added 
in this study because the measured outcomes in this group 
differed from those observed in the diabetic ketoacidosis 
(DKA) and hyperosmolar hyperglycaemic state (HHS) groups. 
Data collected for each patient included demographic group, 
and reason for, duration of and primary outcome of admission. 
HbA1c on admission is not a routine investigation in our 
setting because of cost constraints, and therefore did not 
form part of our analyses.  Cost calculations were determined 
using the following formulae: (i) total costs = patient-specific 
costs + non-patient-specific costs; (ii) patient-specific costs 
= medication costs + laboratory costs + imaging costs + 
procedure costs + clinical staff costs; (iii) non-patient-specific 
costs = capital costs + overhead costs; and (iv) capital costs = 
building costs + equipment costs. All costs were calculated 
utilising public-sector pricing. Patient-specific costs were 
determined using the ‘ingredients approach’, which involves 
identifying the specific components of all services utilised 
during admission.12 Data were collected for each component 
of the patient’s hospital admission (emergency unit (EU), 
HCU, GFJH medical ward and Carnation ward) – duration of 
stay, duration of doctor consultation, quantities and types of 
medication, laboratory investigations, X-rays and procedures 
utilised. Clinical staff costs were calculated per EU visit and 
per inpatient day.  The estimated annual nursing cost was 
calculated as the product of annual cost per nursing shift group 
and the number of shift groups required per annum. The daily 
nursing cost was obtained by dividing the annual nursing cost 
by 365. Doctors’ estimated annual cost was determined as the 
sum of their basic salary, overtime and scarce-skills allowance. 
Doctors’ costs were calculated per hourly consultation with 
the patient. Non-patient-specific costs (i.e. capital costs and 
overhead costs) were obtained from a costing audit of HIV/
AIDS admissions to GFJH in 2003/2004.13 An inflation factor of 
1.188 (obtained from Statistics South Africa) was used to adjust 
the 2003/2004 figures to September 2005.14 
Data were entered onto an Excel (Microsoft) spreadsheet 
and analysed using Microsoft Excel Software 2003. Data were 
expressed as means and medians (range). The University of 
Cape Town’s Research Ethics Committee approved the study.
Results
There were 53 hyperglycaemic emergencies admitted during 
the 2-month survey period (Table I); 32 (60%) were female and 
34 (64%) were Xhosa-speaking. Sepsis (36%), non-compliance 
with therapy (32%) and a new diagnosis of diabetes mellitus 
(11%) accounted for most admissions. No precipitating cause 
was identified in 8%. The remaining 13% of hyperglycaemic 
admissions (‘other’) included diagnoses such as pancreatitis, 
alcohol binge, cerebrovascular accident and chronic renal 
failure. Medical sepsis comprised septicaemia (N = 5), 
pneumonia (N = 4), urinary tract infection (N = 3), pelvic 
inflammatory disease (N = 1) and disseminated tuberculosis (N 
= 1). Surgical sepsis comprised superficial skin abscess (N = 4) 
and gangrene of the foot (N = 1). 
The mean duration of hospital stay was 4 days, and the 
overall in-hospital mortality of hyperglycaemic emergencies 
was 7.5% (Table I). Admission diagnoses for in-hospital deaths 
Table I. Profile of inpatient hyperglycaemic emergencies 
           SDKA MDKA  HODKA HHS  HD  All admissions 
           (N = 9)  (N = 17)  (N = 8)  (N = 7)  (N = 12)  (N = 53)
Median age (range) (yrs) 44 49 56 61 46 49
 (17 - 71) (20 - 72) (22 - 68) (49 - 76) (22 - 65) (17 - 76)
Reason for admission (N) 
Sepsis 3 7 4 2 3 19
Non-compliance 4 7 1 2 3 17
Newly diagnosed 0 1 0 0 5 6
Other 1 1 2 2 1 7
No cause identified 1 1 1 1 0 4
Inpatient deaths (N) 1 1 0 2 0 4
SDKA = severe diabetic ketoacidosis, ; MDKA = mild/moderate diabetic ketoacidosis; HODKA = hyperosmolar diabetic ketoacidosis; HHS =hyperosmolar hyperglycaemic state ; HD = 
hyperglycaemia with dehydration. 
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included septic shock, disseminated tuberculosis, chronic renal 
failure and cerebrovascular accident. All patients admitted 
because of poor compliance, surgical sepsis, ‘unknown cause’ 
or a new diagnosis of diabetes mellitus were discharged home 
in a stable state. Only 64% of medical sepsis patients were 
discharged in a stable state; 21% died and 15% were transferred 
to the nearby tertiary hospital.
We obtained all necessary data for cost calculation for 47 
of the 53 hyperglycaemic emergency cases admitted. The 
mean cost per hyperglycaemic admission was R5 309; this 
varied according to the type of hyperglycaemic emergency 
(Table II). SDKA and HODKA admissions had higher mean 
patient-specific and clinical staff costs compared with other 
groups. Table III indicates that laboratory and clinical staff 
costs, specifically doctor costs, comprised the bulk of EU 
costs. HCU costs predominantly comprised capital costs, 
overhead costs and clinical staff costs, specifically nursing 
costs. Ward admission costs comprised mainly non-patient- 
specific costs. Overall, clinical staff (doctors and nurses), 
capital, and overhead costs comprised 25.8%, 25.6% and 34% 
of hyperglycaemic admission costs respectively. The estimated 
annual cost of hyperglycaemic admissions to GFJH in 2005, 
assuming 26 admissions per month, would have been R1 
688 418. One patient, admitted with HODKA secondary to 
peripheral gangrene, was not included in the cost analysis 
because his admission duration (27.5 days) and admission 
cost (R27 904) greatly exceeded that of any other admission 
surveyed.
Discussion (Table IV) 
It is alarming to note that despite ‘improved’ access to primary 
health care facilities in South Africa, the number and profile of 
hyperglycaemic emergencies admitted to large public hospitals 
remains unchanged from studies conducted 10 - 20 years 
ago. The number of hyperglycaemic emergencies admitted 
per month in our study (approximately 26) is similar to data 
obtained from studies conducted at Groote Schuur Hospital 
(GSH) in 19919 and Baragwanath Hospital (BH) in 1986.10 
However, as the sizes of the drainage populations in these 
two previous studies are not known, incidence comparisons 
are not possible. The commonest reasons for admission in the 
1991 GSH study – sepsis (47%) and non-compliance (26%) 
– remain unchanged in our study. The in-hospital mortality 
rates were 9.1% for GSH (1991)9 and 10.4% for BH (1986).10 Our 
mean in-hospital mortality rate of 7.5%, and the mortality rate 
reported in a more recent study of hyperglycaemic emergencies 
admitted to BH (6.8% for DKA patients and 16.6% for HHS 
patients),15 suggests that mortality rates may be declining. 
It is encouraging to note that the latest BH data are almost 
comparable to data reported by experienced centres in the USA 
(3.4 - 4.6% for DKA and 15% for HHS).16 A shorter duration of 
admission was found in our study (Table II) compared with 
Table II. Cost (South African rands) per hyperglycaemic emergency admission according to diagnostic category
 SDKA MDKA HODKA HHS HD All admissions
 (N = 7) (N = 14) (N = 7) (N = 7) (N = 12) (N = 47)
Mean total duration of admission (days) 4.0 3.4 5.3 3.2 4.5 4.0
Cost per admission       
    Mean patient-specific cost* 1 158.32 570.97 1 090.91 599.93 572.73 775.03
    Mean clinical staff cost 1 712.81 1 093.24 1 953.72 968.03 1 233.60 1 369.81
    Mean overhead cost 1 904.41 1 493.96 2 404.16 1 288.80 2 060.34 1 804.65
    Mean capital cost 1 585.13 1 093.52 1 931.84 955.76 1 434.33 1 360.00
Mean cost per admission 6 360.67 4 251.68 7 380.63 3 812.53 5 300.99 5 309.49
*Excluding clinical staff cost.
SDKA = severe diabetic ketoacidosis; MDKA = mild/moderate diabetic ketoacidosis; HODKA = hyperosmolar diabetic ketoacidosis; HHS = hyperosmolar hyperglycaemic state; HD = 
hyperglycaemia with dehydration.
Table III. Breakdown of cost per patient admitted and estimated annual total cost (South African rands)
 Emergency unit High-care unit Ward Carnation ward Total % Total costs
Duration of admission (hours) 12.6 27.4 46.4 9.0 95.4 
Imaging 28.72 8.09 0 0 36.81 0.7
Medication 57.74 144.01 27.51 5.06 234.32 4.4
Laboratory 270.94 213.85 17.29 1.82 503.90 9.5
Nurses 54.72 662.29 156.18 30.35 903.54 17.0
Doctors 221.59 133.00 93.51 18.17 466.27 8.8
Capital 78.21 620.89 553.37 107.53 1 360.00 25.6
Overheads 128.64 554.51 939.03 182.47 1 804.65 34.0
Total costs 840.56 2 336.64 1 786.89 338.20 5 309.49 
Estimated annual cost     1 688 417.82 
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hyperglycaemic admissions to GSH (7 - 9 days).9 This could be 
attributed to the medical bed pressure experienced at GFJH.17
This is the first South African study evaluating the 
financial costs of hyperglycaemic admissions. The mean 
inpatient cost per hyperglycaemic emergency admission was 
estimated to be just over R5 300 (the equivalent of US$757, 
using an exchange rate of R7 per US$1 in September 2005). 
This figure is unacceptably high, given the potentially 
preventable nature of the problem. Comparatively, in 2005, 
the mean inpatient HIV/AIDS admission cost at GFJH was 
estimated at R4 630 (adjusted for inflation),13 while diabetic 
hyperglycaemic emergencies admitted to USA hospitals in 
2003 cost US$6 500 - 13 000 per patient.18,19 It could be argued 
that we have overestimated the cost of hyperglycaemic 
emergency admissions, since our patients were admitted to a 
HCU. However, our data indicate that a substantial portion 
of the HCU cost was derived from medication, laboratory 
test monitoring and nursing care (50%). If these patients were 
admitted directly to the general wards, as is common practice 
elsewhere, these costs would still be applicable since acutely ill 
patients require more medication, monitoring and nursing care 
regardless of their location within a hospital. From the limited 
data obtained in our study, it appears that hyperglycaemic 
emergencies precipitated by gangrene may be associated with a 
much longer duration of hospital stay, and cost per admission, 
compared with other hyperglycaemic admissions. More data 
are required to validate this finding.
Recommendations
Preventive health care initiatives are urgently needed at a 
primary and secondary-care level. Primary care objectives 
should include: (i) early diagnosis of diabetes; (ii) timely 
identification and treatment of precipitating causes of 
hyperglycaemia; and (iii) education to improve compliance 
with diabetic treatment. Diabetic health education should 
ideally be offered to patients in their home language. Given 
the results of our survey, and the demographic profile of 
South Africans,20 this is unlikely to be English; trained and 
motivated staff who engage patients in their home language 
and with culturally appropriate tools, is therefore a priority. In 
addition, another important reason for non-compliance with 
antihyperglycaemic therapy, i.e. poor access to medication from 
community health care centres because of long waiting times 
and non-availability of drugs, needs to be addressed.
We need to implement cost-effective strategies that improve 
the quality of inpatient care and outcome of admissions. 
Firstly, we need to target the high medical sepsis mortality 
with earlier diagnosis and treatment at primary-care level. 
Secondly, relevant diabetic education needs to be provided 
to all hyperglycaemic emergency patients, in their home 
language, before discharge. Thirdly, a survey of surgical sepsis, 
specifically gangrene, needs to be conducted to determine 
whether inpatient admission duration and costs in this group 
can be reduced significantly.
In conclusion, South Africa is a resource-limited nation 
with a quadruple burden of disease. With the advent of 
district-based health care systems in South Africa the onus is 
on districts to determine cost-effective approaches to treating 
illnesses that cause significant morbidity and mortality. The 
potential adverse outcomes and high costs of hyperglycaemic 
emergency admissions necessitate cost-effective approaches at 
primary-care level to prevent these admissions.
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